Monitoring and AE Management Strategies with Fruquintinib in CRC

Margot O'Neill, PA-C, MHS, and Michael Leung, PharmD, discuss the monitoring and adverse effect management strategies for patients with colorectal cancer who receive fruquintinib.

Related Keywords

,Adverse Event Management ,Colorectal Cancer ,Optimizing Treatment Approaches ,Crc ,Colorectal Cancer Treatment ,Mcrc Treatment ,Adverse Effects ,Adverse Effect Management ,Mae Management ,Monitoring Strategies ,Fruquintinib ,